FIG. 1.

(A-D). Data are shown as mean ± SD. (A). Expression levels of CircCCT3 in PC samples and adjacent non-PC tissue. (B). Expression levels of miR-613 in PC samples and adjacent non-PC tissue. (C) Correlation of CircCCT3 expression with miR-613 expression in PC. (D) Pancreatic carcinoma patients with high CircCCT3 expression (n = 15) exhibited significantly poorer overall survival rate than those patients with low CircCCT3 expression (n = 15), as defined by log-rank test (P = .013).